Timely Knowledge and Clinical Insights on Cancer and Rheumatic Disease

Questions pertaining to cancer and rheumatic disease arise commonly in clinical practice. Clinicians commonly experience concern for the possibility that an atypical or undifferentiated inflammatory syndrome could be caused by an occult malignancy. Conversely, patients often raise justifiable concerns about the possibility a drug for their rheumatic disease may increase their lifetime risk of cancer. Estimates of the risk of cancer for a given rheumatic disease or related to a certain antirheumatic medication seem to vary from study to study.
Source: Rheumatic Disease Clinics of North America - Category: Rheumatology Authors: Tags: Preface Source Type: research